Literature DB >> 14576109

Extended-spectrum beta-lactamase-producing Enterobacteriaceae in community and private health care centers.

Corinne Arpin1, Véronique Dubois, Laure Coulange, Catherine André, Isabelle Fischer, Patrick Noury, Frédéric Grobost, Jean-Philippe Brochet, Jacqueline Jullin, Brigitte Dutilh, Gilberte Larribet, Isabelle Lagrange, Claudine Quentin.   

Abstract

In 1999, 39 of 2,599 isolates of the family Enterobacteriaceae (1.5%) collected by eight private laboratories in the Aquitaine region in France produced an extended-spectrum beta-lactamase (ESBL). Among these were 19 Enterobacter aerogenes isolates; 8 Klebsiella pneumoniae isolates; 6 Escherichia coli isolates; 3 Proteus mirabilis isolates; and 1 isolate each of Serratia marcescens, Morganella morganii, and Providencia stuartii. ESBL producers were isolated from 38 patients, including 33 residents of 11 clinics or nursing homes and 5 ambulatory patients. Seven different ESBLs were characterized. These mainly consisted of TEM-24 (25 isolates) and TEM-21 (9 isolates), but TEM-15 (2 isolates) and TEM-3, TEM-19, SHV-4, and CTX-M-1 (1 isolate each) were also characterized. Seven strains showed the coexistence of different TEM- and/or SHV-encoding genes, including a new SHV-1 variant, SHV-44, defined by the substitution R205L previously reported for SHV-3 in association with S238G. The epidemiology of the ESBL producers was investigated by random amplification of polymorphic DNA, typing by enterobacterial repetitive intergenic consensus PCR, analysis of resistance cotransferred with the ESBL, and analysis of the restriction profiles of the ESBL-encoding plasmids. Of the TEM-24-expressing strains, 18 were E. aerogenes isolates, including 9 from the same clinic, that were representatives of the epidemic clone disseminating in France. Of the TEM-21-producing strains that belonged to different species of the family Enterobacteriaceae (E. coli, K. pneumoniae, and P. mirabilis), 8 were isolated in the same nursing home. Outbreaks due to strain and/or plasmid dissemination in these clinic and nursing home were demonstrated. The presence of ESBL producers in five ambulatory patients probably resulted from nosocomial acquisition. Our data highlight the serious need to monitor patients for ESBL-producing Enterobacteriaceae in general practice.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14576109      PMCID: PMC253776          DOI: 10.1128/AAC.47.11.3506-3514.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  45 in total

1.  Comité de l'Antibiogramme de la Société Française de Microbiologie report 2003.

Authors: 
Journal:  Int J Antimicrob Agents       Date:  2003-04       Impact factor: 5.283

2.  Cloning of SHV-2, OHIO-1, and OXA-6 beta-lactamases and cloning and sequencing of SHV-1 beta-lactamase.

Authors:  J Mercier; R C Levesque
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

3.  Nucleotide sequence of the aacC2 gene, a gentamicin resistance determinant involved in a hospital epidemic of multiply resistant members of the family Enterobacteriaceae.

Authors:  J S Vliegenthart; P A Ketelaar-van Gaalen; J A van de Klundert
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

4.  Structural features related to hydrolytic activity against ceftazidime of plasmid-mediated SHV-type CAZ-5 beta-lactamase.

Authors:  J Péduzzi; M Barthélémy; K Tiwari; D Mattioni; R Labia
Journal:  Antimicrob Agents Chemother       Date:  1989-12       Impact factor: 5.191

5.  Complete amino acid sequence of p453-plasmid-mediated PIT-2 beta-lactamase (SHV-1).

Authors:  M Barthélémy; J Peduzzi; R Labia
Journal:  Biochem J       Date:  1988-04-01       Impact factor: 3.857

6.  A rapid alkaline extraction procedure for screening recombinant plasmid DNA.

Authors:  H C Birnboim; J Doly
Journal:  Nucleic Acids Res       Date:  1979-11-24       Impact factor: 16.971

7.  Nucleotide sequence of the ampicillin resistance gene of Escherichia coli plasmid pBR322.

Authors:  J G Sutcliffe
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

8.  Most Enterobacter aerogenes strains in France belong to a prevalent clone.

Authors:  C Bosi; A Davin-Regli; C Bornet; M Mallea; J M Pages; C Bollet
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

9.  Susceptibility of Enterobacteriaceae to beta-lactam agents and fluoroquinolones: a 3-year survey in France.

Authors:  J Sirot; M H Nicolas-Chanoine; H Chardon; J L Avril; C Cattoen; J C Croix; H Dabernat; T Fosse; J C Ghnassia; E Lecaillon; A Marmonier; M Roussel-Delvallez; C J Soussy; A Trevoux; F Vandenesch; C Dib; N Moniot-Ville; Y Rezvani
Journal:  Clin Microbiol Infect       Date:  2002-04       Impact factor: 8.067

10.  Molecular characterization of the gene encoding SHV-3 beta-lactamase responsible for transferable cefotaxime resistance in clinical isolates of Klebsiella pneumoniae.

Authors:  M H Nicolas; V Jarlier; N Honore; A Philippon; S T Cole
Journal:  Antimicrob Agents Chemother       Date:  1989-12       Impact factor: 5.191

View more
  30 in total

1.  Epidemiology and risk factors of community onset infections caused by extended-spectrum β-lactamase-producing Escherichia coli strains.

Authors:  Cheol-In Kang; Yu Mi Wi; Mi Young Lee; Kwan Soo Ko; Doo Ryeon Chung; Kyong Ran Peck; Nam Yong Lee; Jae-Hoon Song
Journal:  J Clin Microbiol       Date:  2011-12-07       Impact factor: 5.948

2.  Antibiotic resistance rates and phenotypes among isolates of Enterobacteriaceae in French extra-hospital practice.

Authors:  C Quentin; C Arpin; V Dubois; C André; I Lagrange; I Fischer; J-P Brochet; F Grobost; J Jullin; B Dutilh; G Larribet; P Noury
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-02-19       Impact factor: 3.267

3.  Survey of Enterobacteriaceae producing extended-spectrum beta-lactamases in a Slovak hospital: dominance of SHV-2a and characterization of TEM-132.

Authors:  Martina Zarnayová; Eliane Siebor; André Péchinot; Jean-Marie Duez; Helena Bujdáková; Roger Labia; Catherine Neuwirth
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

4.  CTX-M beta-lactamase-producing Escherichia coli in French hospitals: prevalence, molecular epidemiology, and risk factors.

Authors:  Jean-Philippe Lavigne; Hélène Marchandin; Julien Delmas; Jérôme Moreau; Nicole Bouziges; Evelyne Lecaillon; Laurent Cavalie; Hélène Jean-Pierre; Richard Bonnet; Albert Sotto
Journal:  J Clin Microbiol       Date:  2006-11-15       Impact factor: 5.948

5.  Extended-spectrum-beta-lactamase-producing Enterobacteriaceae strains in various types of private health care centers.

Authors:  Corinne Arpin; Laure Coulange; Véronique Dubois; Catherine André; Isabelle Fischer; Sophie Fourmaux; Frédéric Grobost; Jacqueline Jullin; Brigitte Dutilh; Jean-Francois Couture; Patrick Noury; Isabelle Lagrange; Aline Ducastaing; Henri-Pierre Doermann; Claudine Quentin
Journal:  Antimicrob Agents Chemother       Date:  2007-06-25       Impact factor: 5.191

6.  Clinical and molecular analysis of extended-spectrum {beta}-lactamase-producing enterobacteria in the community setting.

Authors:  Corinne Arpin; Véronique Dubois; Jeanne Maugein; Jacqueline Jullin; Brigitte Dutilh; Jean-Philippe Brochet; Gilberte Larribet; Isabelle Fischer; Claudine Quentin
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

7.  Prolonged outbreak of infection due to TEM-21-producing strains of Pseudomonas aeruginosa and enterobacteria in a nursing home.

Authors:  Véronique Dubois; Corinne Arpin; Patrick Noury; Catherine Andre; Laure Coulange; Claudine Quentin
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

8.  Molecular epidemiology of Enterobacteriaceae isolates producing extended-spectrum beta-lactamases in a French hospital.

Authors:  Jean-Philippe Lavigne; Nicole Bouziges; Catherine Chanal; Aba Mahamat; Sylvie Michaux-Charachon; Albert Sotto
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

9.  Urinary tract infection in infants caused by extended-spectrum beta-lactamase-producing Escherichia coli: comparison between urban and rural hospitals.

Authors:  Ming-Fang Cheng; Wan-Ling Chen; I-Fei Huang; Jung-Ren Chen; Yee-Hsuan Chiou; Yao-Shen Chen; Susan Shin-Jung Lee; Wan-Yu Hung; Chih-Hsin Hung; Jiun-Ling Wang
Journal:  Pediatr Nephrol       Date:  2016-03-14       Impact factor: 3.714

10.  Prevalence of community-occurring extended spectrum beta-lactamase-producing Enterobacteriaceae in Brazil.

Authors:  Luciene A R Minarini; Ana C Gales; Izabel C V Palazzo; Ana Lúcia C Darini
Journal:  Curr Microbiol       Date:  2007-04-24       Impact factor: 2.188

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.